chartexchange

Dyadic: 3 Key Takeaways for Long-Term Investors

The Motley Fool | Nov 13, 2026 11:22 AM EST

On its third-quarter 2026 earnings call, held on Nov. 12, 2026, Dyadic (NASDAQ:DYAI) announced a strategy shift toward larger strategic partnerships to scale its protein production platforms. Long-term investors care because Dyadic lacks the capital to fund independent manufacturing, making external licensing deals the primary driver of future revenue. Three things management said stand out. Customer evaluations in cell culture media require extensive testing to prove product consistency before switching suppliers. That dynamic delays the conversion of sample requests into recurring sales. Dyadic chooses to license its production systems to established partners rather than funding stand-alone manufacturing infrastructure. Partnering with companies that own distribution networks reduces capital requirements while expanding market reach. Continue reading

Read original article